Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Anesthesiology
    • Street Drug, 10,000...

    Street Drug, 10,000 times more potent than MORPHINE finding its way to the markets

    Written by Meghna Singhania Published On 2016-05-06T16:22:02+05:30  |  Updated On 6 May 2016 4:22 PM IST
    Street Drug, 10,000 times more potent than MORPHINE finding its way to the markets
    Reports have been flashing of a powerful drug, called W-18 is slowly finding its way to the streets of various parts of the world. The key feature of this drug, is that it appears to be 10,000 times more effective that morphine

    W-18, reportedly a more effective but less addictive painkiller ,first emerged in the research labs at the University of Alberta, Canada three decades ago to some; to others an opiate cooked in the labs of china, before being sold online; claimed to be 10,000 times more powerful than morphine. W-18 has just been spotted in the US and Australia. Though its yet to be given an illegal drug license in the US.

    Still under cover, wherever & whenever uncovered, this fascinating synthetic opiate painkiller is untraceable in a person’s blood or urine, as the medical world has still to come up with tests to trace the drug in the human body.

    In 1984, the W_18 formula was patented in the US and Canada; however it did not find any takers in the pharmaceutical world, due to its maddening potency, forcing it into anonymity reports the Washington post.

    "Whenever this drug starts circulating on the streets you're going to have deaths," Sacramento-based forensic chemist Brian Escamilla told the Calgary Sun. A fact that could be substantiated in a statement made by a graduate student, who once worked on the drug and revealed that mice when injected with W-18 stood up for a minute, only to fall unconscious for five days. On regaining consciousness they were found to be hungry and thirsty, beyond which quite themselves, as reported to David Kroll, Forbes.

    Chemists in China also seem to have laid hands on it, however they seem to have transformed this synthetic opiate from a powerful medical treatment drug to a cheap, toxic, and not-yet-illegal high.

    Compared to Fentanyl- the drug that killed 655 people in Canada between 2009-2014, W-18 is claimed to be 100 times more potent. Connecting fentanyl to the world of crime and seemingly emerging from China ,Martin Schiavetta, a staff sergeant with the Calgary Police Service Drug Unit, told VICE. "Certainly organised crime is behind the importation of fentanyl, and I would make the connection that W-18 would be the same."

    Sweden was the first country to grant W-18 an illegal status; Canada and Australia seem to be pondering still.

    Katie Mettler from The Washington Post reported ,"Then more than 1.1 kilograms of W-18 was discovered in the home of a Florida man, who was sentenced to 10 years in federal prison after he plead guilty to smuggling fentanyl from China. He faced no charges for possessing the W-18, however, because it's not yet illegal in the US.”

    Reports of W-18 resurfacing are filtering from parts of the world, all over again. The first being in 2015 in Canada , when the police seized 110 pills in a drug raid, some of which contained the substance.

    Last week, Health Canada's Drug Analysis Service reported seizure of 4 kilograms of a chemical powder in a fentanyl investigation in December 2015, which turned out to be the W-18 drug."

    A matter of concern remains, that pharma companies have taken little interest in this potent painkiller saying “only tested in mice.”

    At present , nobody knows what W-18 does to humans; how addictive or carrying what kind of side effects; while way ahead in terms of potency in comparison to other tested drugs , the fact remains that there is no scientific data on W-18 since the 80’s.

    "We have no data on absorption, distribution, metabolism, or excretion of the substance. We do not know on what specific receptors W-18 acts. We know nothing about receptor binding affinities. We know nothing of the acute effects of the substance," reports toxicologist-run blog, Dose Makes The Poison.

    According to the Sydney Morning Herald the Australians though conscious of its presence on the island, are not taking it seriously, as they know that it is not being picked off the streets. Though citizens have the freedom to order the opiate, they are turning away to tried and tested opiates, fearing the drugs potency.

    "It's certainly available for Australian consumers to order but we've never really seen a big uptake of any of the new opioids in Australia, with consumers seeming to prefer the more traditional licit and illicit opioids," said NDARC research officer Joe Van Buskirk,

    There is information on W-18 being equated with heroin and cocaine and being distributed in Philadelphia; however one finds the government still thinking on how to handle this potent painkiller.



    morphineopioidsphentanylw-18
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna Singhania
    Meghna Singhania
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok